Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation in mantle cell lymphoma: results of a Fondazione Italiana Linfomi (FIL) multicentre, randomised, phase 3 trial
Marco Ladetto, Sergio Cortelazzo, Simone Ferrero, Andrea Evangelista, Michael Mian, Rita Tavarozzi, Manuela Zanni, Federica Cavallo, Alice Di Rocco, Vittorio Stefoni, Chiara Pagani, Alessandro Re, Annalisa Chiappella, Monica Balzarotti, Vittorio Ruggero Zilioli, María Gomes da Silva, Luca Arcaini, Anna Lia Molinari, Filippo Ballerini, Andrés J.M. Ferreri, Benedetta Puccini, Fabio Benedetti, Piero Maria Stefani, Franco Narni, Ivana Casaroli, Caterina Stelitano, Giovannino Ciccone, Umberto Vitolo, Maurizio Martelli
Topics & Concepts
Mantle cell lymphomaVincristineMedicineInternal medicineTransplantationRituximabCyclophosphamideAutologous stem-cell transplantationGastroenterologyLenalidomidePopulationSurgeryOncologyLymphomaMultiple myelomaChemotherapyEnvironmental healthLymphoma Diagnosis and TreatmentMultiple Myeloma Research and TreatmentsHematopoietic Stem Cell Transplantation